Product Images Losartan Potassium

The text presented seems to be a chart or a graph showing the comparison between Atenolol and Losartan Potassium drugs in terms of patients reaching the primary endpoint. The graph also provides information on the adjusted risk reduction, which is 13%, with a p-value of 0.021. This graph has different study months represented on the X-axis and the percentage of patients reaching the primary endpoint on the Y-axis.*

This is a medical report with the comparison of the effectiveness of Atenolol and Losartan Potassium in reducing the risk of fatal/non-fatal stroke. The report shows the percentage of patients in each medication group and the adjusted risk reduction, which is 25% with a p-value of 0.001. The graph shows the study months on the X-axis and the number of patients at risk on the Y-axis. No further information is available.*

Not-Available.*

The text is showing a chart that compares the percentage of patients with an event between two treatments: Losartan Potassium Tablet and a placebo. The chart indicates that there is a 16.1% risk reduction when taking Losartan Potassium Tablet, as well as a p-value of 0.022. The meaning of "El" and "22 E 48" is not available.*

This is a medication package of Losartan Potassium Tablets USP, with each tablet containing 100 mg of Losartan potassium. The package contains 10 tablets that can be used as per the prescribing information, precautions, and warnings available in the product insert. The tablets should be stored in a controlled room temperature and protected from light. This package does not have child-resistant features and is intended for institutional use only. This package was manufactured and distributed by American Health Packaging and is a product of Zydus Pharmaceuticals USA Inc. Pharmacist dispensing the medication should provide the patient with the necessary information. If the package is dispensed for outpatient use, a child-resistant container should be used.*

Losartan Potassium Tablets are available to treat high blood pressure. The package contains ten tablets, with each tablet consisting of 50mg of Losartan potassium. It is advised to see the product insert for full instructions, precautions, and warnings. Store the product in 20°C to 25°C, with excursions allowed between 15° to 30°C. The RX Only package does not have a child-resistant cover and only meant for institutional use. Dispensed for outpatient use should be stored in a child-resistant container. Check the drug product in the package before using it, and do not risk using it if the blister is broken. The medication is from NDC #68382-136, Zydus Pharmaceuticals USA Inc. American Health Packaging has packaged and distributed it, which is a Cardinal Health subsidiary.*

Losartan Potassium Tablets is a medication containing 25 mg of Losartan potassium, USP per tablet. It is used to treat high blood pressure. The product must be stored away from light and within a temperature range of 20° to 25° G (68° to 77° F) with permitted excursions between 15° to 30° C (59° to 86° F). The Unit Dose package is not child-resistant and is intended for institutional use only. The package contains 10 tablets. If dispensed for outpatient use, a child-resistant container should be utilized. The drug product is from Zydus Pharmaceuticals USA Inc. This product should be dispensed with patient information for each patient. If the blister containing the medicine is torn or broken, it should not be used for protection. American Health Packaging, an AmerisourceBergen Company, is responsible for packaging and distribution. *